SocGen And AllianceBernstein Are Finally Getting Pally

SocGen And AllianceBernstein Are Finally Getting Pally

over 1 year ago2 mins

The long-touted joint venture between Société Générale’s and AllianceBernstein’s stock businesses appears to be going ahead, according to news out on Tuesday.

What does this mean?

The world of professional stock investing hasn’t been a happy place in recent years. The rise and rise of cheap, index-based investing has thrown a wet blanket on professional investment services, and the toxic spillover has splashed firms that cater to professional investors, as Société Générale (SocGen) and Bernstein do. The “strategic” reason for the venture, then, is that SocGen, strong in trading, and AllianceBernstein, strong in research, go together like peanut butter and jelly. But the deal’s probably a bid for strength in unity too, with the firms hoping their combined weight will keep them rooted amid the gale-force industry headwinds.


Why should I care?

For markets: Being clued-up will cost you.

Knowledge is expensive, at least for professional investors: a 2018 European rule change meant they could no longer use their clients’ cash to cover the fees they pay for research. So faced with the prospect of reaching into their own pockets, thrifty fund managers started hacking at the prices they paid research firms. That left the used-and-abused companies with a choice: ramp up the caliber and, in turn, their prices, or change their focus. SocGen originally chose to leave the business behind, but it looks like the firm couldn't stay gone for long.

The bigger picture: Where the pros go, retail follows

Retail investors have a long list of cheap and easy trading avenues to choose from, so services really need to stand out from the crowd if they want to bring in users. One method’s proven popular so far: adding thought-provoking, actionable insights to a platform. If nothing else, the spate of deals in the pro world shows that quality research is still highly valued. Now, where could a retail investor find a platform bursting with world-class, bite-sized Insights… *cough cough*.



All the daily investing news and insights you need in one subscription.

Disclaimer: These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment advisor.

/3 Your free quarterly content is about to expire. Uncover the biggest trends and opportunities. Subscribe now for 50%. Cancel anytime.

© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG